{"id":{"repo_id":"kennesaw","oai_identifier":"oai:digitalcommons.kennesaw.edu:integrbiol_etd-1017"},"canonical_url":"https://search.dev.ndltd.org/etd/kennesaw/oai:digitalcommons.kennesaw.edu:integrbiol_etd-1017","repository":{"repo_id":"kennesaw","name":"Kennesaw State University","base_url":"https://digitalcommons.kennesaw.edu/do/oai/"},"display":{"title":"Transcriptional Regulation of kal-1 in the Nematode Caenorhabditis elegans","abstract":"<p>X-linked Kallmann syndrome (KS) is a genetic disease that is caused by loss-of-function mutations in the human <em>kal-1</em> gene. The disorder consists of a loss of sense-of-smell coupled with failure to undergo spontaneous puberty. At the cellular level, KS phenotypes are caused by olfactory neurons’ failure to properly migrate to the olfactory bulb. This also prevents gonadotropin-releasing hormone neuroendocrine cells from migrating to the pituitary, preventing the pulsatile release of sex hormones at puberty. While many <em>kal-1</em> interacting proteins have been studied in model organisms, little is known about the regulatory mechanisms that control <em>kal-1</em>’s expression. Since a 5.27kb promoter is sufficient to rescue loss-of-function defects, we hypothesized that most of the <em>kal-1</em> control elements are contained in this region. In order to address our hypothesis, a lineage of <em>P-kal-1-GFP</em> was produced to determine the cell-specific expression pattern. Using a promoter deletion assay the location of tissue-specific enhancers was determined. In addition, a transcription factor candidate gene screen was performed in which a single transcription factor, <em>cnd-1</em>, was found to regulate <em>kal-1</em> with variable penetrance. From this we hypothesized that the regulation would be cell autonomous. As such, <em>cnd-1</em> loss-of-function mutations may have similar embryonic phenotypes as <em>kal-1 </em>and could involve other, intermediate transcription factors. A co-expression assay found that the regulation of <em>kal-1</em> by <em>cnd-1</em> was cell autonomous. Using an embryonic lethality assay and timing gastrulation cleft duration, <em>cnd-1</em> loss-of-function was found to have synergistic lethality with mutations in the <em>efn-4</em> gene, similar to those seen in <em>kal-1</em>, although they did not obviously affect neuroblast migration and gastrulation cleft duration. To identify additional regulatory targets of <em>cnd-1</em>, we performed a comparative transcriptome of embryonic gene expression. No potential transcription factor intermediates or other nematode orthologs of Kallmann syndrome genes were found to be differentially expressed in the transcriptome with a q-value of less than 0.05. The transcriptome suggested that <em>cnd-1</em> regulation covered a variety of pathways including ubiquitination and synaptic vesicle control. Finally, this thesis details the beginning of a new endeavor to determine if CND-1 interacts with the <em>kal-1</em> regulatory region in a direct manner.</p>","abstract_html":"&lt;p&gt;X-linked Kallmann syndrome (KS) is a genetic disease that is caused by loss-of-function mutations in the human &lt;em&gt;kal-1&lt;/em&gt; gene. The disorder consists of a loss of sense-of-smell coupled with failure to undergo spontaneous puberty. At the cellular level, KS phenotypes are caused by olfactory neurons’ failure to properly migrate to the olfactory bulb. This also prevents gonadotropin-releasing hormone neuroendocrine cells from migrating to the pituitary, preventing the pulsatile release of sex hormones at puberty. While many &lt;em&gt;kal-1&lt;/em&gt; interacting proteins have been studied in model organisms, little is known about the regulatory mechanisms that control &lt;em&gt;kal-1&lt;/em&gt;’s expression. Since a 5.27kb promoter is sufficient to rescue loss-of-function defects, we hypothesized that most of the &lt;em&gt;kal-1&lt;/em&gt; control elements are contained in this region. In order to address our hypothesis, a lineage of &lt;em&gt;P-kal-1-GFP&lt;/em&gt; was produced to determine the cell-specific expression pattern. Using a promoter deletion assay the location of tissue-specific enhancers was determined. In addition, a transcription factor candidate gene screen was performed in which a single transcription factor, &lt;em&gt;cnd-1&lt;/em&gt;, was found to regulate &lt;em&gt;kal-1&lt;/em&gt; with variable penetrance. From this we hypothesized that the regulation would be cell autonomous. As such, &lt;em&gt;cnd-1&lt;/em&gt; loss-of-function mutations may have similar embryonic phenotypes as &lt;em&gt;kal-1 &lt;/em&gt;and could involve other, intermediate transcription factors. A co-expression assay found that the regulation of &lt;em&gt;kal-1&lt;/em&gt; by &lt;em&gt;cnd-1&lt;/em&gt; was cell autonomous. Using an embryonic lethality assay and timing gastrulation cleft duration, &lt;em&gt;cnd-1&lt;/em&gt; loss-of-function was found to have synergistic lethality with mutations in the &lt;em&gt;efn-4&lt;/em&gt; gene, similar to those seen in &lt;em&gt;kal-1&lt;/em&gt;, although they did not obviously affect neuroblast migration and gastrulation cleft duration. To identify additional regulatory targets of &lt;em&gt;cnd-1&lt;/em&gt;, we performed a comparative transcriptome of embryonic gene expression. No potential transcription factor intermediates or other nematode orthologs of Kallmann syndrome genes were found to be differentially expressed in the transcriptome with a q-value of less than 0.05. The transcriptome suggested that &lt;em&gt;cnd-1&lt;/em&gt; regulation covered a variety of pathways including ubiquitination and synaptic vesicle control. Finally, this thesis details the beginning of a new endeavor to determine if CND-1 interacts with the &lt;em&gt;kal-1&lt;/em&gt; regulatory region in a direct manner.&lt;/p&gt;","abstract_has_math":false,"creators":["Mielko, Zachery E"],"institution":null,"degree_name":"Master of Science in Integrative Biology (MSIB)","degree_level":"Thesis","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":["Joel McNeal","Tsai-Tien Tseng","Michael Van Dyke"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-07-28T07:00:00Z","date_published":"2017-07-28T07:00:00Z","updated_at":"2026-07-24T02:43:17Z","subjects":["Kallmann Syndrome","Gene Regulation","Biology","Genetics","Integrative Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.kennesaw.edu/integrbiol_etd/17","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Joel McNeal","Tsai-Tien Tseng","Michael Van Dyke"]},{"key":"dc:creator","label":"Author","values":["Mielko, Zachery E"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2022-07-20T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Integrative Biology (MSIB)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Kallmann Syndrome","Gene Regulation","Biology","Genetics","Integrative Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.kennesaw.edu/integrbiol_etd/17"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>X-linked Kallmann syndrome (KS) is a genetic disease that is caused by loss-of-function mutations in the human <em>kal-1</em> gene. The disorder consists of a loss of sense-of-smell coupled with failure to undergo spontaneous puberty. At the cellular level, KS phenotypes are caused by olfactory neurons’ failure to properly migrate to the olfactory bulb. This also prevents gonadotropin-releasing hormone neuroendocrine cells from migrating to the pituitary, preventing the pulsatile release of sex hormones at puberty. While many <em>kal-1</em> interacting proteins have been studied in model organisms, little is known about the regulatory mechanisms that control <em>kal-1</em>’s expression. Since a 5.27kb promoter is sufficient to rescue loss-of-function defects, we hypothesized that most of the <em>kal-1</em> control elements are contained in this region. In order to address our hypothesis, a lineage of <em>P-kal-1-GFP</em> was produced to determine the cell-specific expression pattern. Using a promoter deletion assay the location of tissue-specific enhancers was determined. In addition, a transcription factor candidate gene screen was performed in which a single transcription factor, <em>cnd-1</em>, was found to regulate <em>kal-1</em> with variable penetrance. From this we hypothesized that the regulation would be cell autonomous. As such, <em>cnd-1</em> loss-of-function mutations may have similar embryonic phenotypes as <em>kal-1 </em>and could involve other, intermediate transcription factors. A co-expression assay found that the regulation of <em>kal-1</em> by <em>cnd-1</em> was cell autonomous. Using an embryonic lethality assay and timing gastrulation cleft duration, <em>cnd-1</em> loss-of-function was found to have synergistic lethality with mutations in the <em>efn-4</em> gene, similar to those seen in <em>kal-1</em>, although they did not obviously affect neuroblast migration and gastrulation cleft duration. To identify additional regulatory targets of <em>cnd-1</em>, we performed a comparative transcriptome of embryonic gene expression. No potential transcription factor intermediates or other nematode orthologs of Kallmann syndrome genes were found to be differentially expressed in the transcriptome with a q-value of less than 0.05. The transcriptome suggested that <em>cnd-1</em> regulation covered a variety of pathways including ubiquitination and synaptic vesicle control. Finally, this thesis details the beginning of a new endeavor to determine if CND-1 interacts with the <em>kal-1</em> regulatory region in a direct manner.</p>"]},{"key":"dc:title","label":"Title","values":["Transcriptional Regulation of kal-1 in the Nematode Caenorhabditis elegans"]}]}],"canonical_facts":{"dc:contributor":["Joel McNeal","Tsai-Tien Tseng","Michael Van Dyke"],"dc:creator":["Mielko, Zachery E"],"dc:date.available":["2022-07-20T07:00:00Z"],"dc:description.abstract":["<p>X-linked Kallmann syndrome (KS) is a genetic disease that is caused by loss-of-function mutations in the human <em>kal-1</em> gene. The disorder consists of a loss of sense-of-smell coupled with failure to undergo spontaneous puberty. At the cellular level, KS phenotypes are caused by olfactory neurons’ failure to properly migrate to the olfactory bulb. This also prevents gonadotropin-releasing hormone neuroendocrine cells from migrating to the pituitary, preventing the pulsatile release of sex hormones at puberty. While many <em>kal-1</em> interacting proteins have been studied in model organisms, little is known about the regulatory mechanisms that control <em>kal-1</em>’s expression. Since a 5.27kb promoter is sufficient to rescue loss-of-function defects, we hypothesized that most of the <em>kal-1</em> control elements are contained in this region. In order to address our hypothesis, a lineage of <em>P-kal-1-GFP</em> was produced to determine the cell-specific expression pattern. Using a promoter deletion assay the location of tissue-specific enhancers was determined. In addition, a transcription factor candidate gene screen was performed in which a single transcription factor, <em>cnd-1</em>, was found to regulate <em>kal-1</em> with variable penetrance. From this we hypothesized that the regulation would be cell autonomous. As such, <em>cnd-1</em> loss-of-function mutations may have similar embryonic phenotypes as <em>kal-1 </em>and could involve other, intermediate transcription factors. A co-expression assay found that the regulation of <em>kal-1</em> by <em>cnd-1</em> was cell autonomous. Using an embryonic lethality assay and timing gastrulation cleft duration, <em>cnd-1</em> loss-of-function was found to have synergistic lethality with mutations in the <em>efn-4</em> gene, similar to those seen in <em>kal-1</em>, although they did not obviously affect neuroblast migration and gastrulation cleft duration. To identify additional regulatory targets of <em>cnd-1</em>, we performed a comparative transcriptome of embryonic gene expression. No potential transcription factor intermediates or other nematode orthologs of Kallmann syndrome genes were found to be differentially expressed in the transcriptome with a q-value of less than 0.05. The transcriptome suggested that <em>cnd-1</em> regulation covered a variety of pathways including ubiquitination and synaptic vesicle control. Finally, this thesis details the beginning of a new endeavor to determine if CND-1 interacts with the <em>kal-1</em> regulatory region in a direct manner.</p>"],"dc:identifier":["https://digitalcommons.kennesaw.edu/integrbiol_etd/17"],"dc:subject":["Kallmann Syndrome","Gene Regulation","Biology","Genetics","Integrative Biology"],"dc:title":["Transcriptional Regulation of kal-1 in the Nematode Caenorhabditis elegans"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science in Integrative Biology (MSIB)"]},"updated_at":"2026-07-24T02:43:17Z"}